4/A: Nexalin Technology Insider Filing: Elson and Osser Report Changes in Beneficial Ownership

Marilyn Elson and Leonard Osser, both with ties to Nexalin Technology, report changes in their beneficial ownership of common stock, including the acquisition of 700,000 shares at $0.

Summary

• Marilyn Elson, a director and 10% owner of Nexalin Technology, filed an amended Form 4 on October 2, 2024, reporting changes in beneficial ownership.
• The original filing date was September 25, 2024.
• The earliest transaction date reported is September 30, 2024.
• Elson acquired 700,000 shares of common stock at a price of $0.
• Following the reported transaction, Elson beneficially owns 1,535,244 shares.
• The filing indicates shared voting and dispositive power with spouse Leonard Osser.
• Leonard Osser, also a director and 10% owner, jointly filed the Form 4.
• The filing includes shares owned jointly with spouse Marilyn Elson.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting changes in ownership. The acquisition at $0 could be related to stock options or grants, which doesn't necessarily indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be a signal to investors.

Stakeholder Impact

• Shareholders may be interested in the trading activity of directors and large shareholders as it can provide insights into their confidence in the company's prospects.

Key Dates